Grow Therapy raised $88M in a Series C funding led by Sequoia Capital and supported by Goldman Sachs Alternatives and PLUS Capital to advance effective mental healthcare.

Apr 08, 2024•over 1 year ago

Amount Raised

$88 Million

Round Type

series c

New YorkMedicalHealth Care

Investors

Plus CapitalGoldman Sachs AlternativesSequoia Capital

Description

Grow Therapy announced the closing of its $88 million Series C investment round, with the lead investor being Sequoia Capital, alongside support from Goldman Sachs Alternatives and PLUS Capital alongside artists and athletes. They also launched an enhanced measurement-informed care system to elevate the care experience and make value-based behavioral care accessible for all patient populations.

Company Information

Company

Grow Therapy

Location

New York, New York, United States

About

Grow Therapy (Grow) is a mental health platform empowering providers to deliver exceptional in-person and online therapy and psychiatric care. Its rigorously vetted network of 23,000 providers delivers high-quality care covered by insurance, with 180 million Americans able to access Grow through their health plan. Grow Therapy has raised $178 million, and key investors include Sequoia Capital, Goldman Sachs Alternatives, Transformation Capital, TCV, SignalFire and Plus Capital.

Related People

5 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends